SEASONAL ALLERGIC RHINITIS
Clinical trials for SEASONAL ALLERGIC RHINITIS explained in plain language.
Never miss a new study
Get alerted when new SEASONAL ALLERGIC RHINITIS trials appear
Sign up with your email to follow new studies for SEASONAL ALLERGIC RHINITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New allergy drug shows promise in early trial
Symptom relief Not yet recruitingThis study tests a new medicine called AK139 for people with moderate to severe seasonal allergic rhinitis (hay fever). About 111 adults aged 18 to 65 will receive either the drug or a placebo to see if it reduces nasal symptoms like sneezing, stuffiness, and runny nose. The tria…
Matched conditions: SEASONAL ALLERGIC RHINITIS
Phase: PHASE2 • Sponsor: Akeso • Aim: Symptom relief
Last updated Jun 15, 2026 18:55 UTC
-
New shot aims to ease teen hay fever
Symptom relief Not yet recruitingThis study tests a new injection called stapokibart in 15 teenagers (ages 12-17) with seasonal allergic rhinitis (hay fever). The goal is to see if the shot is safe and how the body processes it. Participants will continue their usual allergy medications during the study.
Matched conditions: SEASONAL ALLERGIC RHINITIS
Phase: PHASE2 • Sponsor: Chengdu Kangnuoxing Biopharma,Inc. • Aim: Symptom relief
Last updated Jun 11, 2026 12:08 UTC